Immunoassays News on immunoassay systems and applications. Quidel Preliminary Q3 Revenues Rise, Easily Beat Analysts' Estimate Quidel expects approximately $406.0 million in COVID-19 revenues compared with $375.7 million a year ago. OncoHost Further Assessing Protein Signature for Predicting NSCLC Patients' Immunotherapy Response Premium In data presented at the ESMO Congress, a signature of eight proteins and two clinical parameters appeared to differentiate responders and non-responders. BioMérieux H1 Revenues Rise 7 Percent Growth in immunoassay business segment sales was offset by a decline in molecular biology sales, the firm said. Oxford BioDynamics Awarded Grant to Apply EpiSwitch to ICI Cancer Therapy Response The two-year PACT grant will fund the application of the EpiSwitch technology to the analysis of primary and acquired ICI resistance in several clinical trials. Quidel Q2 Revenues Dip 12 Percent; Misses on Revenues and EPS Estimates Quidel CEO Douglas Bryant said the firm's base business grew 24 percent year over year, excluding COVID and influenza products. Aug 4, 2021 OraSure Technologies Q2 Revenues Nearly Double Aug 4, 2021 Thermo Fisher Scientific, Access Bio, LumiraDx Get FDA EUAs for SARS-CoV-2 Tests Aug 3, 2021 FDA Grants EUAs for SARS-CoV-2 Tests From Thermo Fisher Scientific, Phase Scientific International Jul 26, 2021 Quidel, Beckman Coulter Settle Legal Dispute Over Cardiac Immunoassay Business Jul 23, 2021 Oncimmune, Dana Farber Ink Deal to Discover Autoantibody Biomarkers of Immunotherapy Response Jul 22, 2021 Roche Reports Diagnostics Revenue Up 51 Percent in H1 Jul 12, 2021 Thermo Fisher Scientific, Ellume Get FDA Emergency Use Authorizations for SARS-CoV-2 Tests Jun 29, 2021 BGI Americas, Advaite Form SARS-CoV-2 Testing Partnership Jun 15, 2021 Study Explores Usefulness of NfL as Biomarker Across Range of Neurological Conditions Premium Jun 8, 2021 Amazon, Diabetomics Get FDA Emergency Use Authorizations for Coronavirus Tests May 26, 2021 FDA Grants Emergency Use Authorizations for SARS-CoV-2 Tests From Harvard, NowDiagnostics May 20, 2021 With Finder Platform, Baebies Works to Expand Options for Neonatal Dx Testing Premium May 13, 2021 Fujifilm, Helio Health Collaborate on Blood-Based Liver Cancer Test May 6, 2021 Quidel Q1 Revenues More Than Double but Miss Expectations May 6, 2021 Becton Dickinson Fiscal Q2 Revenues up 15 Percent May 5, 2021 OraSure Technologies Q1 Revenues Jump 85 Percent Apr 27, 2021 BioMérieux Reports 10 Percent Q1 Revenue Growth, Lowers Full-Year Guidance Apr 23, 2021 PathogenDx, Southern California Permanente Medical, Inova Diagnostics SARS-CoV-2 Tests Get FDA EUAs Apr 22, 2021 Immunovia Preparing to Launch Laboratory-Developed Test for Pancreatic Cancer Premium Apr 20, 2021 Abbott Q1 Diagnostics Revenues More Than Double on COVID-19 Testing Load More Breaking News SUPER Psychosis Study Presented at ASHG Digs Into Relationships of Rare Variants, Phenotypes People in the News: New Appointments at Myriad Genetics, Becton Dickinson, Delfi Diagnostics, More In Brief This Week: Virginia Commonwealth University, Dovetail Genomics, Lucid Diagnostics, and More New Products Posted to GenomeWeb: Bio-Rad, PerkinElmer, Ares Genetics, Purigen Biosystems, More Genetron Health, Fosun Ink Commercialization Deal for Seq-MRD Test in China MultiMuTHER Team Tracks Expression, Metabolite Relationships in Aging TwinsUK Participants The Scan More Boosters for US Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes. From a Pig A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports. For Privacy's Sake Wired reports that more US states are passing genetic privacy laws. Science Paper on How Poaching Drove Evolution in African Elephants In Science this week: poaching has led to the rapid evolution of tuskless African elephants.